Liau Gene

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Liau Gene's trades of Stoke Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
453.33
Quantity 56,888 -24.9%
Value US$1,864,451
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-04 2021-03-02
PlS Planned sale
3,569 -17.1%
280.11
US$4,169,466 		3,569 -17.1% 280.11 US$4,169,466
2021-03-04 2021-03-02
PlS Planned sale
53,635 -20.7%
37.91
US$4,784,010 		53,635 -20.7% 37.91 US$4,784,010
2021-03-04 2020-12-28
S Sale
56,888 -24.9%
453.33
US$1,864,451 		56,888 -24.9% 453.33 US$1,864,451
2020-10-20 2020-10-19
PlS Planned sale
7,225 -34.9%
38.42
US$277,586 		7,225 -34.9% 38.42 US$277,586
2020-10-20 2020-10-19
PlS Planned sale
24,775 -54.5%
37.64
US$932,578 		24,775 -54.5% 37.64 US$932,578
2020-10-20 2020-10-16
PlS Planned sale
5,851 -30.2%
40.00
US$234,042 		5,851 -30.2% 40.00 US$234,042
2020-10-13 2020-10-13
PlS Planned sale
1,649 -10.9%
40.00
US$65,960 		1,649 -10.9% 40.00 US$65,960
2020-06-03 2020-06-01
PlS Planned sale
1,230 -8.4%
27.48
US$33,802 		1,230 -8.4% 27.48 US$33,802
2020-06-03 2020-06-01
PlS Planned sale
7,875 -34.8%
26.91
US$211,921 		7,875 -34.8% 26.91 US$211,921
2020-06-03 2020-06-01
PlS Planned sale
10,895 -32.5%
25.82
US$281,314 		10,895 -32.5% 25.82 US$281,314
2020-05-26 2020-05-22
PlS Planned sale
7,500 -35.7%
30.00
US$225,000 		7,500 -35.7% 30.00 US$225,000